Martek Biosciences Corp. (MM) (MATK) Quote

news just out
AMSTERDAM -- Royal DSM NV, the world's biggest maker of vitamins, said Tuesday it will bid $1.09 billion (euro830 million) in cash for U.S. biotech firm Martek Biosciences Corp

Millenium323: Should we make a go of it here? I'd be willing to moderate or co-moderate the board and expand the i-box.

I have followed this company for an eon.

Martek Biosciences climbs on strong 2Q results
Martek shares rise, avoiding broader market slump, as overseas sales boost fiscal 2Q results

Symbol Price Change
MATK 22.37 +3.12

On Friday June 4, 2010, 12:23 pm EDT
NEW YORK (AP) -- Shares of Martek Biosciences Corp. surged Friday, as a recent acquisition boosted the nutritional supplement maker's fiscal second-quarter profit and sales far above Wall Street's expectations.

THE SPARK: Martek reported its fiscal second-quarter results after the markets closed on Thursday. The company acquired Amerifit Brands during the quarter, and it said sales in Asia were strong.

THE BIG PICTURE: Martek's infant formula supplement sales slumped in the last few quarters -- partly of a because a dip in the U.S. birth rate -- but they rebounded in the latest quarter. The Columbia, Md., company attributed most of the improvement to better sales overseas.

THE ANALYSIS: Food and drink revenue growth is returning, said Canaccord Genuity analyst Scott Van Winkle. In a note to clients, Van Winkle said the company has a strong product pipeline and will start selling those products next year. He thinks that could boost the stock further

SHARE ACTION: The broader market slumped Friday due to disappointing jobs data, but Martek stock climbed $2.85, or 14.8 percent, to $22.10 in midday trading. The stock has ranged from $17.09 to $25.43 over the past year.

Super move today/